FDA to require diversity plan for clinical trials
US regulatory agency makes ‘big change’ to increase the number of participants from under-represented groups in drug testing.
Continue Reading
US regulatory agency makes ‘big change’ to increase the number of participants from under-represented groups in drug testing.
Continue Reading
Join the Discussion